Cytrx reported 1.53M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Bioline Rx BLRX:US 1.29M 80K
Brainstorm Cell Therapeutics BCLI:US $ 1.66M 863K
Celldex Therapeutics CLDX:US $ 5.82M 1.52M
Curis CRIS:US $ 4.33M 267K
Cytrx CYTR:US 1.53M 354.61K
Glaxosmithkline GSK:US 2.5B 6M
Johnson & Johnson JNJ:US $ 6B 73M
Karyopharm Therapeutics KPTI:US $ 35.1M 1.43M
Northwest Biotherapeutics NWBO:US 6.65M 721K
Novartis NVS:US 3.6B 109M
Seattle Genetics SGEN:US $ 180.28M 15.15M
Takeda 4502:JP 212.01B 7.83B